BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mckiernan PJ, Ganoza A, Squires JE, Squires RH, Vockley J, Mazariegos G, Soltys K, Sun Q, Sindhi R. Evolving Trends in Liver Transplant for Metabolic Liver Disease in the United States. Liver Transpl 2019;25:911-21. [DOI: 10.1002/lt.25433] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Raghu VK, Carr-Boyd PD, Squires JE, Vockley J, Goldaracena N, Mazariegos GV. Domino transplantation for pediatric liver recipients: Obstacles, challenges, and successes. Pediatr Transplant 2021;25:e14114. [PMID: 34448327 DOI: 10.1111/petr.14114] [Reference Citation Analysis]
2 Zhang T, Hickner B, Cotton R, Nguyen Galvan NT, Vierling JM, O'Mahony C, Goss JA, Rana A. Donor Gamma-Glutamyl Transferase Is Associated With Liver Allograft Discard and Failure. Prog Transplant 2021;31:101-7. [PMID: 33729047 DOI: 10.1177/15269248211002800] [Reference Citation Analysis]
3 Jiang YZ, Zhou GP, Wu SS, Kong YY, Zhu ZJ, Sun LY. Safety and efficacy of liver transplantation for methylmalonic acidemia: A systematic review and meta-analysis. Transplant Rev (Orlando) 2021;35:100592. [PMID: 33422927 DOI: 10.1016/j.trre.2020.100592] [Reference Citation Analysis]
4 Olivieri G, Martinelli D, Longo D, Grimaldi C, Liccardo D, Di Meo I, Pietrobattista A, Sidorina A, Semeraro M, Dionisi-Vici C. Ethylmalonic encephalopathy and liver transplantation: long-term outcome of the first treated patient. Orphanet J Rare Dis 2021;16:229. [PMID: 34011365 DOI: 10.1186/s13023-021-01867-5] [Reference Citation Analysis]
5 Hadžić N. Metabolic Indications for Pediatric Liver Transplantation: A Slow Train Coming. Liver Transpl 2019;25:829-30. [PMID: 31021032 DOI: 10.1002/lt.25478] [Reference Citation Analysis]
6 Squires JE. When Considering Liver Transplant for Children with Glycogen Storage Disease 1b. Liver Transpl 2019;26:12-3. [DOI: 10.1002/lt.25688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Tran LT, Carullo PC, Banh DPT, Vitu C, Davis PJ. Pediatric Liver Transplantation: Then and Now. J Cardiothorac Vasc Anesth 2020;34:2028-35. [PMID: 32241678 DOI: 10.1053/j.jvca.2020.02.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
8 Henkel SAF, Salgado CM, Reyes-Mugica M, Soltys KA, Strauss K, Mazariegos GV, Squires RH, McKiernan PJ, Zhang X, Squires JE. Long-term liver transplant outcomes for progressive familial intrahepatic cholestasis type 1: The Pittsburgh experience. Pediatr Transplant 2021;:e14108. [PMID: 34339082 DOI: 10.1111/petr.14108] [Reference Citation Analysis]
9 Breilyn MS, Wasserstein MP. Established and Emerging Treatments for Patients with Inborn Errors of Metabolism. Neoreviews 2020;21:e699-707. [PMID: 33004565 DOI: 10.1542/neo.21-10-e699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Guilder L, Prada CE, Saenz S, Jain-Ghai S, Karp N, Mazariegos G, Ratko S, Salvarinova R, Mercimek-Andrews S. Hyperleucinosis during infections in maple syrup urine disease post liver transplantation. Mol Genet Metab Rep 2021;27:100763. [PMID: 33996492 DOI: 10.1016/j.ymgmr.2021.100763] [Reference Citation Analysis]
11 Sanada Y, Sakuma Y, Onishi Y, Okada N, Yamada N, Hirata Y, Miyahara G, Katano T, Horiuchi T, Omameuda T, Lefor AK, Sata N. Outcomes After Living Donor Liver Transplantation in Pediatric Patients with Inherited Metabolic Diseases. Ann Transplant 2021;26:e932994. [PMID: 34593749 DOI: 10.12659/AOT.932994] [Reference Citation Analysis]
12 Paik JM, Golabi P, Younossi Y, Saleh N, Nhyira A, Younossi ZM. The Growing Burden of Disability Related to Chronic Liver Disease in the United States: Data From the Global Burden of Disease Study 2007-2017. Hepatol Commun 2021;5:749-59. [PMID: 34027266 DOI: 10.1002/hep4.1673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ewing CB, Soltys KA, Strauss KA, Sindhi R, Vockley J, McKiernan P, Squires RH, Bond G, Ganoza A, Khanna A, Mazariegos GV, Squires JE. Metabolic Control and "Ideal" Outcomes in Liver Transplantation for Maple Syrup Urine Disease. J Pediatr 2021:S0022-3476(21)00558-8. [PMID: 34153280 DOI: 10.1016/j.jpeds.2021.06.028] [Reference Citation Analysis]
14 Sood V, Squires JE, Mazariegos GV, Vockley J, McKiernan PJ. Living Related Liver Transplantation for Metabolic Liver Diseases in Children. J Pediatr Gastroenterol Nutr 2021;72:11-7. [PMID: 32969959 DOI: 10.1097/MPG.0000000000002952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Leiskau C, Junge N, Pfister ED, Goldschmidt I, Mutschler F, Laue T, Ohlendorf J, Nasser H, Beneke J, Richter N, Vondran F, Baumann U. Recipient-Specific Risk Factors Impairing Patient and Graft Outcome after Pediatric Liver Transplantation-Analysis of 858 Transplantations in 38 Years. Children (Basel) 2021;8:641. [PMID: 34438532 DOI: 10.3390/children8080641] [Reference Citation Analysis]
16 McKiernan PJ, Squires JE, Squires RH, Vockley J, Mazariegos GV, Soltys K, Ganoza A, Strauss K, Khanna A, Sindhi R. Liver transplant for inherited metabolic disease among siblings. Clin Transplant 2020;34:e14090. [PMID: 32955727 DOI: 10.1111/ctr.14090] [Reference Citation Analysis]